Faurschou M - Search Results

1

ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships.

Mahr A, Heijl C, Le Guenno G, Faurschou M. Mahr A, et al. Among authors: faurschou m. Best Pract Res Clin Rheumatol. 2013 Feb;27(1):45-56. doi: 10.1016/j.berh.2012.12.003. Best Pract Res Clin Rheumatol. 2013. PMID: 23507056 Review.

2

High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders.

Faurschou M, Nielsen OJ, Jensen MK, Hasselbalch HC. Faurschou M, et al. Am J Hematol. 2000 Oct;65(2):136-40. doi: 10.1002/1096-8652(200010)65:2<136::aid-ajh8>3.0.co;2-6. Am J Hematol. 2000. PMID: 10996831 Free article.

3

Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis.

Walsh M, Faurschou M, Berden A, Flossmann O, Bajema I, Hoglund P, Smith R, Szpirt W, Westman K, Pusey CD, Jayne DR; European Vasculitis Study Group. Walsh M, et al. Among authors: faurschou m. Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1571-6. doi: 10.2215/CJN.00100114. Epub 2014 Jun 26. Clin J Am Soc Nephrol. 2014. PMID: 24970876 Free PMC article. Clinical Trial.

4

Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

Faurschou M, Westman K, Rasmussen N, de Groot K, Flossmann O, Höglund P, Jayne DR; European Vasculitis Study Group. Faurschou M, et al. Arthritis Rheum. 2012 Oct;64(10):3472-7. doi: 10.1002/art.34547. Arthritis Rheum. 2012. PMID: 22614882 Free article. Clinical Trial.

5

Incidence of granulomatosis with polyangiitis (Wegener's) in Greenland and the Faroe Islands: epidemiology of an ANCA-associated vasculitic syndrome in two ethnically distinct populations in the North Atlantic area.

Faurschou M, Helleberg M, Obel N, Baslund B. Faurschou M, et al. Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S52-5. Epub 2013 Apr 9. Clin Exp Rheumatol. 2013. PMID: 23663682

6

Anti-B cell antibody therapies for inflammatory rheumatic diseases.

Faurschou M, Jayne DR. Faurschou M, et al. Annu Rev Med. 2014;65:263-78. doi: 10.1146/annurev-med-070912-133235. Epub 2013 Oct 18. Annu Rev Med. 2014. PMID: 24160940 Review.

7

Pronounced Risk of Fractures among Elderly Men Affected by Granulomatosis with Polyangiitis.

Faurschou M, Baslund B, Obel N. Faurschou M, et al. J Rheumatol. 2015 Sep;42(9):1667-71. doi: 10.3899/jrheum.141566. Epub 2015 Aug 1. J Rheumatol. 2015. PMID: 26233512

8

Cancer preceding Wegener's granulomatosis: a case-control study.

Faurschou M, Mellemkjaer L, Sorensen IJ, Thomsen BS, Dreyer L, Baslund B. Faurschou M, et al. Rheumatology (Oxford). 2009 Apr;48(4):421-4. doi: 10.1093/rheumatology/kep009. Epub 2009 Feb 12. Rheumatology (Oxford). 2009. PMID: 19213850

9

Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.

Faurschou M, Sorensen IJ, Mellemkjaer L, Loft AG, Thomsen BS, Tvede N, Baslund B. Faurschou M, et al. J Rheumatol. 2008 Jan;35(1):100-5. Epub 2007 Oct 15. J Rheumatol. 2008. PMID: 17937462

10

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.

Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, Baslund B. Faurschou M, et al. Arthritis Rheum. 2009 Apr;60(4):1187-92. doi: 10.1002/art.24386. Arthritis Rheum. 2009. PMID: 19333952 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters